Silence Therapeutics prices $175M ADS offering at $13.50 per share

Silence Therapeutics plc

Priced 12,962,963 ADSs at $13.50 each; gross proceeds ~$175M before expenses.
Underwriters' 30-day option for up to 1,944,444 additional ADSs; net proceeds ~$164.0M (~$188.7M if option exercised).
Closing expected Aug 13, 2026; Jefferies, Morgan Stanley, Cantor and William Blair act as joint book-runners.
Underwriters purchase price $12.69 per ADS; offering under shelf registration on Form S-3.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.